Agilent Presents Thought Leader Award to Professor Hyun Joo An
August 28 2019 - 9:58PM
Business Wire
Korean researcher recognized for her work in glycomics and
biopharma applications
Agilent Technologies Inc. (NYSE: A) announced today that
Professor Hyun Joo An has received an Agilent Thought Leader Award
in support of her work in glycomics and biopharmaceutical
applications.
Dr. Hyun Joo An is a professor at the Graduate School of
Analytical Science and Technology, Chungnam National University, in
Daejeon, South Korea. She also heads the Asia Glycomics Reference
Site (AGRS), a collaboration between Agilent and the university’s
Graduate School of Analytical Science and Technology. The AGRS
supports the Asia-Pacific scientific community and industry in the
field of glycoanalysis and glycotechnology, promoting collaborative
research to develop and enhance the biosimilars industry, which is
helping scientists to develop new treatments to cure or prevent
diseases.
“By supporting the work of leading researchers like Professor
An, Agilent is contributing to advance the fields of glycan
analysis, biopharmaceutical characterization, and quality control,”
stated executive sponsor of the award Kevin Killeen, Ph.D.,
Business Transition Manager for Agilent-ProZyme. “The research is
expected to result in much-needed reference libraries for the mass
spectral analysis and identification of glycans. The importance is
clear when you realize that more than half of the approved
biopharmaceuticals are glycosylated and that regulators around the
world require glycosylation characterization of therapeutic
glycoproteins.”
Dr. Killeen noted that identifying new structural entities,
which is gaining increased emphasis among researchers, could have
profound implications for the treatment of various cancers,
Alzheimer’s disease, heart ailments, and infectious diseases.
“I am honored by this award from Agilent, which will allow us to
build a glycome database using HILIC LC/MS. This is a great
opportunity to accelerate our mass spectrometry-based glycomic
research and deepen our partnership,” said Prof. An. “Detailed
glycomic analyses are important to assess biotherapeutic quality
and establish the equivalency of biosimilars now coming into the
market. As biopharmaceutical glycosylation is becoming more
complex, the glycan database will be essential because it will
enable automated and user-independent analysis.”
“Chungnam National University is particularly prominent in the
field of bio and pharmaceutical technology, and we are very pleased
to work with a global innovation company such as Agilent,” stated
Professor Deog-Seong Oh, president of the Chungnam National
University.
“The importance of industry-university cooperation is emphasized
in times when open innovation is required through linkages between
companies and universities,” added Dr. Young-Seak Lee, director,
Foundation of Research and Business, at Chungnam National
University. “In this regard, the collaboration between Chungnam
National University and Agilent is of great significance. We will
do our best to make this project a success.”
The Agilent Thought Leader Award promotes fundamental scientific
advances by contributing financial support, products, and expertise
to the research of influential thought leaders in the life
sciences, diagnostics, and chemical analysis space. Further
information, including previous award recipients, is available at
Agilent's Thought Leader Award web page.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,550 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190828005800/en/
Naomi Goumillout Agilent Technologies, Inc. +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2023 to Sep 2024